InflaRx IFRX
NASDAQ IFRX
$1.21 -0.10 (-7.63%)
At close: Nov 10, 2026 · 4:00 PM EST

InflaRx (IFRX) Common Stock Issued (2018 - 2025)

Updated

InflaRx's Common Stock Issued was $22.9 million in Q4 2025.

Analysis

InflaRx (IFRX) Common Stock Issued (2018 - 2025) Analysis & Trends

For FY2025, Common Stock Issued at InflaRx came in at $40.47 million.

  • Common Stock Issued shows a five-year compound annual growth rate of 28.1% (FY2020 to FY2025).
  • In earlier years, Common Stock Issued was $1.19 million in FY2024 (-98.1%), $61.36 million in FY2023, $2.48 million in FY2022 (-96.8%) and $78.29 million in FY2021 (+567.8%).
  • The Q4 2025 figure marks the highest quarterly Common Stock Issued since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 743.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 87.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 InflaRx 85.79 Mn -160.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 22.90 Mn
Mar 31, 2025 16.98 Mn
Dec 31, 2023 60.77 Mn
Sep 30, 2023 -61.49 Mn
Jun 30, 2023 61.63 Mn
Mar 31, 2023 133,037.50
Dec 31, 2021 74.58 Mn
Sep 30, 2021 -76.82 Mn
Jun 30, 2021 78.45 Mn
Mar 31, 2021 1.16 Mn
Dec 31, 2020 11.65 Mn
Sep 30, 2019 1,864.94
Dec 31, 2018 377.80
Sep 30, 2018 -61.11 Mn
API Access

InflaRx Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=IFRX&period=max&api_key=YOUR_API_KEY